Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
73 Leser
Artikel bewerten:
(0)

Mindray Receives its Largest Order of Patients Monitors in Canada

SHENZHEN, China, Jan. 19, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices worldwide, together with Ultra-Portable, Inc., Mindray's partner and distributor in Canada, today announced Mindray North America's largest order of patient monitors in Canada. The installation of the patient monitors has already begun at the Centre hospitalier universitaire de Québec (CHUQ), which is comprised of three hospitals: L'Hôtel-Dieu de Québec, Hôpital Saint-François d'Assise and Centre hospitalier de l'Université Laval (CHUL). Over 90 patient monitors are being installed at the hopital L'Hotel-Dieu de Québec.

"At the CHUQ, we were looking for a patient monitoring and life support solution that could be installed in all patient care units of the oldest hospital site in North America. A timely and integrated solution was required. Mindray North America products offer an exceptional quality to price ratio. They simply enabled us to make things happen." stated Mr. Christian Moisan, Director of Biomedial Engineering, CHUQ.

"The goal of Ultra-Portable and Mindray North America is to offer the Canadian market an alternative in patient monitoring by providing solutions and services with excellent quality that can also generate positive return on investment." said Mr. Hani Sardi, General Manager, Ultra-Portable, Inc.

"Canada is one of our key target markets outside the US. With our proximity and the benefits of NAFTA, we are going to make larger investment in Canada to ensure customers like CHUQ receive outstanding service and support. Mindray North America will be a top tier supplier in Canada and we are focusing all our effort to offer high quality products and services to meet every need of the Canadian healthcare market." said Mr. Ricardo Cristancho, Vice President of International Sales, Mindray North America.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems.

For investor and media inquiries please contact In the U.S.: Hoki Luk Western Bridge, LLC Tel: +1-646-808-9150 Email: hoki.luk@westernbridgegroup.com In China: Cathy Gao Mindray Medical International Limited Tel: +86-755-2658-2620 Email: cathy.gao@mindray.com

Mindray Medical International Limited

CONTACT: in the U.S., Hoki Luk, Western Bridge, LLC, +1-646-808-9150,
hoki.luk@westernbridgegroup.com; or in China, Cathy Gao, Mindray Medical
International Limited, +86-755-2658-2620, cathy.gao@mindray.com

Web Site: http://ir.mindray.com/

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.